Title
Pre/perimenopausal (preMeno) women receiving palbociclib (PAL) for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2‒) advanced breast cancer (ABC) in a real-world setting: Treatment patterns from POLARIS
Files
Link to Full Text
Download Full Text
Publication Date
12-2020
Disciplines
Oncology
Clinical Institute
Cancer
Clinical Institute
Women & Children
Department
Oncology
Conference / Event Name
San Antonio Breast Cancer Symposium
Location
Virtual Symposium
Book / Chapter Details
Poster ID: PS7-19
Recommended Citation
Karuturi, MS; Garrett, A; Blum, JL; Anderson, J; Jensen, E; Pluard, T; Stanton, Thomas; Manning, K; Cappelleri, JC; Beery, F; Wang, Y; and Tripathy, D, "Pre/perimenopausal (preMeno) women receiving palbociclib (PAL) for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2‒) advanced breast cancer (ABC) in a real-world setting: Treatment patterns from POLARIS" (2020). Books, Presentations, Posters, Etc.. 128.
https://digitalcommons.providence.org/other_pubs/128
